These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37809473)

  • 41. Key stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
    Jebara T; Cunningham S; MacLure K; Pallivalapila A; Awaisu A; Al Hail M; Stewart D
    Res Social Adm Pharm; 2020 Mar; 16(3):405-414. PubMed ID: 31253499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of RWE to Inform Regulatory, Public Health Policy, and Intervention Priorities for the Developing World.
    McNair D; Lumpkin M; Kern S; Hartman D
    Clin Pharmacol Ther; 2022 Jan; 111(1):44-51. PubMed ID: 34655224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
    Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
    J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-world evidence for regulatory decision-making: updated guidance from around the world.
    Burns L; Le Roux N; Kalesnik-Orszulak R; Christian J; Dudinak J; Rockhold F; Khozin S; O'Donnell J
    Front Med (Lausanne); 2023; 10():1236462. PubMed ID: 38020096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A review of stakeholder recommendations for defining fit-for-purpose real-world evidence algorithms.
    Beyrer J; Abedtash H; Hornbuckle K; Murray JF
    J Comp Eff Res; 2022 May; 11(7):499-511. PubMed ID: 35296149
    [No Abstract]   [Full Text] [Related]  

  • 46. Toward a better understanding about real-world evidence.
    Liu M; Qi Y; Wang W; Sun X
    Eur J Hosp Pharm; 2022 Jan; 29(1):8-11. PubMed ID: 34857642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
    Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1604-1611. PubMed ID: 33251991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
    Hurwitz JT; Brown M; Graff JS; Peters L; Malone DC
    J Manag Care Spec Pharm; 2017 Jun; 23(6):613-620. PubMed ID: 28530524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of multi-level barriers and facilitators in a large diabetic retinopathy screening program in federally qualified health centers: a qualitative study.
    Bastos de Carvalho A; Lee Ware S; Belcher T; Mehmeti F; Higgins EB; Sprang R; Williams C; Studts JL; Studts CR
    Implement Sci Commun; 2021 May; 2(1):54. PubMed ID: 34022946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Facilitators and barriers to the implementation of new critical care practices during COVID-19: a multicenter qualitative study using the Consolidated Framework for Implementation Research (CFIR).
    Silver S; Jones KC; Redmond S; George E; Zornes S; Barwise A; Leppin A; Dong Y; Harmon LA; Kumar VK; Kordik C; Walkey AJ; Drainoni ML
    BMC Health Serv Res; 2023 Mar; 23(1):272. PubMed ID: 36941593
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021).
    Maruszczyk K; Aiyegbusi OL; Cardoso VR; Gkoutos GV; Slater K; Collis P; Keeley T; Calvert MJ
    Contemp Clin Trials; 2022 Sep; 120():106882. PubMed ID: 35973663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward.
    Kc S; Lin LW; Bayani DBS; Zemlyanska Y; Adler A; Ahn J; Chan K; Choiphel D; Genuino-Marfori AJ; Kearney B; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Akmal Shafie A; Sui B; Suwantika A; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Teerawattananon Y; Wee HL
    Int J Health Policy Manag; 2023; 12():6858. PubMed ID: 37579427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Strategies to Address Current Challenges in Real-World Evidence Generation in Japan.
    Laurent T; Lambrelli D; Wakabayashi R; Hirano T; Kuwatsuru R
    Drugs Real World Outcomes; 2023 Jun; 10(2):167-176. PubMed ID: 37178273
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tactical Considerations for Designing Real-World Studies: Fit-for-Purpose Designs That Bridge Research and Practice.
    Dreyer NA; Mack CD
    Pragmat Obs Res; 2023; 14():101-110. PubMed ID: 37786592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
    Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
    Value Health; 2022 Oct; 25(10):1663-1672. PubMed ID: 36241338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leveraging the Consolidated Framework for Implementation Research to Develop the American College of Rheumatology's Toolkit for Implementation of Rheumatoid Arthritis Outcome Measures in Clinical Practice: A Qualitative Study.
    Nasrallah C; Schmajuk G; Hamblin A; Wilson C; Kersey E; Young C; Katz P; Bajaj P; Downey C; Bartels C; Zell J; Danila MI; Ferguson S; Barton JL; DeQuattro K; Yazdany J
    Arthritis Care Res (Hoboken); 2024 Dec; 76(12):1647-1656. PubMed ID: 39099213
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceed with Caution When Using Real World Data and Real World Evidence.
    Kim HS; Kim JH
    J Korean Med Sci; 2019 Jan; 34(4):e28. PubMed ID: 30686950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teaching Real-World Evidence: Protocol for a Systematic Review.
    Lam C; van Velthoven MH; Chaudhury H; Meinert E
    JMIR Res Protoc; 2020 Jan; 9(1):e16941. PubMed ID: 32012110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Real-world evidence for coverage decisions: opportunities and challenges.
    Hampson G; Towse A; Dreitlein WB; Henshall C; Pearson SD
    J Comp Eff Res; 2018 Dec; 7(12):1133-1143. PubMed ID: 30411972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.